Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2882 | PRLD Prelude Therapeutics Incorporated - Common Stock | 6.67 USD | +0.60% | +17.02% | +71.91% | +421.09% | 532.29 M USD | ||
| 2889 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 11.25 USD | +2.93% | -4.98% | +12.61% | +170.43% | 550.01 M USD | ||
| 2895 | CABA Cabaletta Bio, Inc. - Common Stock | 3.09 USD | -1.28% | +5.82% | +12.36% | +88.41% | 523.90 M USD | ||
| 2898 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.33 USD | -3.27% | -10.42% | -11.17% | -42.13% | 530.05 M USD | ||
| 2920 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.23 USD | -2.26% | -5.07% | +10.32% | +111.03% | 508.97 M USD | ||
| 2923 | MPLT MapLight Therapeutics, Inc. - Common Stock | 11.31 USD | +0.89% | -1.65% | -11.71% | -40.47% | 524.53 M USD | ||
| 2939 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.97 USD | -0.75% | -5.25% | +16.42% | +53.28% | 488.41 M USD | ||
| 2950 | EVMN Evommune, Inc. Common Stock | 13.47 USD | -3.65% | -7.87% | +20.16% | -22.23% | 488.85 M USD | ||
| 2956 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.48 USD | -3.24% | -6.28% | -13.35% | +611.11% | 477.88 M USD | ||
| 2959 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.62 USD | +0.62% | +17.39% | +5.88% | -22.12% | 489.76 M USD | ||
| 2960 | PRTA Prothena Corporation plc - Ordinary Shares | 9.29 USD | -1.69% | +3.22% | +4.62% | +6.05% | 476.92 M USD | ||
| 2962 | RZLT Rezolute, Inc. - Common Stock | 4.94 USD | -2.95% | +5.78% | -0.20% | -29.43% | 475.68 M USD | ||
| 2968 | PBYI Puma Biotechnology Inc - Common Stock | 9.13 USD | -1.19% | +3.05% | +13.56% | +72.26% | 471.29 M USD | ||
| 2971 | EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +6.64% | +15.97% | +8.16% | 468.42 M USD | ||
| 2979 | BNTC Benitec Biopharma Inc. - Common Stock | 13.00 USD | -3.56% | +1.40% | +12.07% | -21.73% | 446.61 M USD | ||
| 2982 | OCGN Ocugen, Inc. - Common Stock | 1.36 USD | -2.16% | 0.00% | +8.80% | +34.65% | 461.19 M USD | ||
| 3000 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.98 USD | -5.55% | +1.16% | -7.79% | -21.40% | 449.10 M USD | ||
| 3015 | AGMB AgomAb Therapeutics NV - ADRs representing one | 13.03 USD | -1.66% | -5.31% | +3.74% | -11.36% | 445.20 M USD | ||
| 3019 | EYPT EyePoint, Inc. - Common Stock | 5.01 USD | -5.83% | +10.84% | -59.86% | -58.25% | 431.92 M USD | ||
| 3030 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | 0.00% | +1.69% | +13.74% | -20.27% | 432.21 M USD |
Noticias Biotechnology Stocks
Las acciones de Alto Neuroscience alcanzan máximos históricos a 35,42 dólares
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |